XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2019   254,842,949      
Beginning balance at Dec. 31, 2019 $ 334,619 $ 2,548 $ 408,667 $ (23,927) $ (52,669)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 74,589       74,589
Other comprehensive loss (5,284)     (5,284)  
Dividends declared (415,748)       (415,748)
Profit-sharing plan shares, net (in shares)   (549,834)      
Profit‑sharing plan shares, net (6,970) $ (5)     (6,965)
Shares issued in connection with deferred compensation plan, net (in shares)   2,984,531      
Shares issued in connection with deferred compensation plan, net (1,877) $ 30     (1,907)
Deferred compensation plan elective participant deferrals 2,602   2,602    
Payment of shareholder Put and Call rights (in shares)   (128,176)      
Payment of shareholder Put and Call rights (1,454) $ (1)     (1,453)
Common Stock Purchase Agreement, net (in shares)   169      
Common Stock Purchase Agreement, net (57)       (57)
Stock option exercises, net (in shares)   3,506,103      
Stock option exercises, net 4,158 $ 35 7,741   (3,618)
Shares issued for stock grants, net (in shares)   17,411      
Shares issued for stock grants 219   219    
Stock-based compensation expense 22,510   22,510    
Shares related to restricted stock, net (in shares)   1,553,883      
Shares related to restricted stock, net (134) $ 15 (16)   (133)
Ending balance (in shares) at Sep. 30, 2020   262,227,036      
Ending balance at Sep. 30, 2020 7,173 $ 2,622 441,723 (29,211) (407,961)
Beginning balance (in shares) at Jun. 30, 2020   259,209,355      
Beginning balance at Jun. 30, 2020 379,744 $ 2,592 415,883 (28,404) (10,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 5,844       5,844
Other comprehensive loss (807)     (807)  
Dividends declared (400,311)       (400,311)
Profit-sharing plan shares, net (in shares)   (164,266)      
Profit‑sharing plan shares, net (2,542) $ (1)     (2,541)
Shares issued in connection with deferred compensation plan, net (in shares)   24,800      
Shares issued in connection with deferred compensation plan, net (47)       (47)
Deferred compensation plan elective participant deferrals 804   804    
Stock option exercises, net (in shares)   1,321,475      
Stock option exercises, net 4,985 $ 13 5,538   (566)
Stock-based compensation expense 19,517   19,517    
Shares related to restricted stock, net (in shares)   1,835,672      
Shares related to restricted stock, net (14) $ 18 (19)   (13)
Ending balance (in shares) at Sep. 30, 2020   262,227,036      
Ending balance at Sep. 30, 2020 7,173 $ 2,622 441,723 (29,211) (407,961)
Beginning balance (in shares) at Dec. 31, 2020   272,154,504      
Beginning balance at Dec. 31, 2020 341,599 $ 2,722 741,113 (26,233) (376,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 51,788       51,788
Other comprehensive loss (55,647)     (55,647)  
Shares issued related to acquisition (in shares)   3,141,342      
Shares issued related to acquisition 182,390 $ 31 182,359    
Purchase of capped call options, net of tax of $12,584 (39,021)   (39,021)    
Dividends declared (25,076)       (25,076)
Shares issued in connection with deferred compensation plan, net (in shares)   2,290,999      
Shares issued in connection with deferred compensation plan, net (65,684) $ 23     (65,707)
Deferred compensation plan elective participant deferrals 2,020   2,020    
Deferred compensation plan modification (4,739)   (4,739)    
Shares issued in connection with Executive Bonus Plan, net (in shares)   190,619      
Shares issued in connection with Executive Bonus Plan, net 9,429 $ 2 16,013   (6,586)
Shares issued in connection with employee stock purchase plan (in shares)   104,716      
Shares issued in connection with employee stock purchase plan 3,408 $ 1 3,845   (438)
Stock option exercises, net (in shares)   4,269,335      
Stock option exercises, net (29,949) $ 42 4,987   (34,978)
Shares issued for stock grants, net (in shares)   7,824      
Shares issued for stock grants 450   450    
Stock-based compensation expense 14,383   14,383    
Shares related to restricted stock, net (in shares)   (120,775)      
Shares related to restricted stock, net (6,353) $ (1)     (6,352)
Ending balance (in shares) at Sep. 30, 2021   282,038,564      
Ending balance at Sep. 30, 2021 378,998 $ 2,820 921,410 (81,880) (463,352)
Beginning balance (in shares) at Jun. 30, 2021   281,189,127      
Beginning balance at Jun. 30, 2021 471,814 $ 2,812 910,951 (54,886) (387,063)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (50,128)       (50,128)
Other comprehensive loss (26,994)     (26,994)  
Dividends declared (8,485)       (8,485)
Shares issued in connection with deferred compensation plan, net (in shares)   88,920      
Shares issued in connection with deferred compensation plan, net (3,772) $ 1     (3,773)
Deferred compensation plan elective participant deferrals 527   527    
Deferred compensation plan modification (4,739)   (4,739)    
Shares issued in connection with Executive Bonus Plan, net (in shares)   41,172      
Shares issued in connection with Executive Bonus Plan, net 2,422   4,292   (1,870)
Shares issued in connection with employee stock purchase plan (in shares)   104,716      
Shares issued in connection with employee stock purchase plan 3,408 $ 1 3,845   (438)
Stock option exercises, net (in shares)   612,277      
Stock option exercises, net (5,246) $ 6 699   (5,951)
Stock-based compensation expense 5,835   5,835    
Shares related to restricted stock, net (in shares)   2,352      
Shares related to restricted stock, net (5,644)       (5,644)
Ending balance (in shares) at Sep. 30, 2021   282,038,564      
Ending balance at Sep. 30, 2021 $ 378,998 $ 2,820 $ 921,410 $ (81,880) $ (463,352)